Viewing Study NCT05690503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2026-01-26 @ 1:11 AM
Study NCT ID: NCT05690503
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-16
First Post: 2022-12-30
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial
Sponsor: New York State Psychiatric Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Post-acute Sequelae of COVID-19 View
None Depressive Symptoms View
None Cognitive Dysfunction View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ketamine View
None PASC View
None Long Covid View